Novo Nordisk A/S
October 7th, 2024Morgan Stanley’s Slimmon says U.S. infrastructure is ‘very powerful’ – MASHAHER
- October 1st, 2024
East Coast ports strike, ILA union work stop strands billions in trade – MASHAHER
- September 24th, 2024
Novo Nordisk CEO testifies at Senate over weight loss drug prices – MASHAHER
- September 18th, 2024
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says – MASHAHER
- September 12th, 2024
Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs – MASHAHER
- August 8th, 2024
Eli Lilly’s second quarter suggests it’s gaining in weight loss race – MASHAHER
- August 6th, 2024
Stock market today: Live updates – MASHAHER
- August 3rd, 2024
Eli Lilly Zepbound, Mounjaro available after shortages, FDA says – MASHAHER
- August 1st, 2024
Eli Lilly weight loss drug Zepbound cuts heart failure risks in study – MASHAHER
- July 11th, 2024
Drugmakers are racing to develop weight loss pills – MASHAHER
- July 11th, 2024
Jim Cramer on Hims & Hers Health stock – MASHAHER
- July 10th, 2024
FTC to sue PBMs over drug prices including insulin – MASHAHER
No more posts
No more posts